{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,27]],"date-time":"2022-12-27T03:51:20Z","timestamp":1672113080675},"reference-count":0,"publisher":"MJH Life Sciences","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,12,7]]},"DOI":"10.46883\/onc.2020.3412.0522","type":"journal-article","created":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T14:36:30Z","timestamp":1609770990000},"page":"522-534","source":"Crossref","is-referenced-by-count":1,"title":["Recent Advances in Antibody-Drug Conjugates for Lymphoma"],"prefix":"10.46883","author":[{"given":"Brad","family":"Kahl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Russler-Germain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"25947","published-online":{"date-parts":[[2020,12,8]]},"container-title":["ONCOLOGY"],"original-title":[],"language":"en","deposited":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T14:36:31Z","timestamp":1609770991000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cancernetwork.com\/view\/recent-advances-in-antibody-drug-conjugates-for-lymphoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,7]]},"references-count":0,"URL":"https:\/\/doi.org\/10.46883\/onc.2020.3412.0522","relation":{},"ISSN":["0890-9091"],"issn-type":[{"value":"0890-9091","type":"print"}],"subject":[],"published":{"date-parts":[[2020,12,7]]}}}